A Case of Tenofovir-associated Fanconi Syndrome in Patient with Chronic Hepatitis B
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Kim, D. | - |
dc.contributor.author | Lee, J. | - |
dc.contributor.author | Kim, D.H. | - |
dc.contributor.author | Kang, K. | - |
dc.contributor.author | Suh, S.J. | - |
dc.contributor.author | Jung, Y.K. | - |
dc.contributor.author | Yim, H.J. | - |
dc.date.accessioned | 2021-09-04T08:50:49Z | - |
dc.date.available | 2021-09-04T08:50:49Z | - |
dc.date.created | 2021-06-17 | - |
dc.date.issued | 2016 | - |
dc.identifier.issn | 1598-9992 | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/91383 | - |
dc.description.abstract | Tenofovir disoproxil fumarate (TDF) is one of the most widely used treatment options for human immunodeficiency virus (HIV) and HBV infections. Despite its efficacy and safety, some cases of nephrotoxicity have been reported in the treatment of HIV patients. Even more recently, very few cases of Fanconi syndrome associated with tenofovir therapy in HBV monoinfection have been reported. Herein, we report a case of a 47-year-old male with an HBV monoinfection, who developed Fanconi syndrome and a secondary osteomalacia with multiple bone pain. After TDF withdrawal and supplementation of calcitriol, his renal function was reverted. Although the overall risk of TDF-associated nephrotoxicity is very low, both glomerular and tubular function should be monitored in patients undergoing TDF treatment. | - |
dc.language | Korean | - |
dc.language.iso | ko | - |
dc.subject | antivirus agent | - |
dc.subject | calcifediol | - |
dc.subject | phosphate | - |
dc.subject | tenofovir | - |
dc.subject | bone | - |
dc.subject | case report | - |
dc.subject | diagnostic imaging | - |
dc.subject | Fanconi Syndrome | - |
dc.subject | glomerulus filtration rate | - |
dc.subject | Hepatitis B, Chronic | - |
dc.subject | human | - |
dc.subject | kidney tubule absorption | - |
dc.subject | male | - |
dc.subject | metabolism | - |
dc.subject | middle aged | - |
dc.subject | osteomalacia | - |
dc.subject | Antiviral Agents | - |
dc.subject | Bone and Bones | - |
dc.subject | Calcifediol | - |
dc.subject | Fanconi Syndrome | - |
dc.subject | Glomerular Filtration Rate | - |
dc.subject | Hepatitis B, Chronic | - |
dc.subject | Humans | - |
dc.subject | Male | - |
dc.subject | Middle Aged | - |
dc.subject | Osteomalacia | - |
dc.subject | Phosphates | - |
dc.subject | Renal Reabsorption | - |
dc.subject | Tenofovir | - |
dc.title | A Case of Tenofovir-associated Fanconi Syndrome in Patient with Chronic Hepatitis B | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Jung, Y.K. | - |
dc.identifier.doi | 10.4166/kjg.2016.68.6.317 | - |
dc.identifier.scopusid | 2-s2.0-85021848517 | - |
dc.identifier.bibliographicCitation | The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi, v.68, no.6, pp.317 - 320 | - |
dc.relation.isPartOf | The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi | - |
dc.citation.title | The Korean journal of gastroenterology = Taehan Sohwagi Hakhoe chi | - |
dc.citation.volume | 68 | - |
dc.citation.number | 6 | - |
dc.citation.startPage | 317 | - |
dc.citation.endPage | 320 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.identifier.kciid | ART002176209 | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scopus | - |
dc.description.journalRegisteredClass | kci | - |
dc.subject.keywordPlus | antivirus agent | - |
dc.subject.keywordPlus | calcifediol | - |
dc.subject.keywordPlus | phosphate | - |
dc.subject.keywordPlus | tenofovir | - |
dc.subject.keywordPlus | bone | - |
dc.subject.keywordPlus | case report | - |
dc.subject.keywordPlus | diagnostic imaging | - |
dc.subject.keywordPlus | Fanconi Syndrome | - |
dc.subject.keywordPlus | glomerulus filtration rate | - |
dc.subject.keywordPlus | Hepatitis B, Chronic | - |
dc.subject.keywordPlus | human | - |
dc.subject.keywordPlus | kidney tubule absorption | - |
dc.subject.keywordPlus | male | - |
dc.subject.keywordPlus | metabolism | - |
dc.subject.keywordPlus | middle aged | - |
dc.subject.keywordPlus | osteomalacia | - |
dc.subject.keywordPlus | Antiviral Agents | - |
dc.subject.keywordPlus | Bone and Bones | - |
dc.subject.keywordPlus | Calcifediol | - |
dc.subject.keywordPlus | Fanconi Syndrome | - |
dc.subject.keywordPlus | Glomerular Filtration Rate | - |
dc.subject.keywordPlus | Hepatitis B, Chronic | - |
dc.subject.keywordPlus | Humans | - |
dc.subject.keywordPlus | Male | - |
dc.subject.keywordPlus | Middle Aged | - |
dc.subject.keywordPlus | Osteomalacia | - |
dc.subject.keywordPlus | Phosphates | - |
dc.subject.keywordPlus | Renal Reabsorption | - |
dc.subject.keywordPlus | Tenofovir | - |
dc.subject.keywordAuthor | Fanconi syndrome | - |
dc.subject.keywordAuthor | Hepatitis B virus | - |
dc.subject.keywordAuthor | Kidney tubules, proximal | - |
dc.subject.keywordAuthor | Osteomalacia | - |
dc.subject.keywordAuthor | Tenofovir | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.